Wintergreen Acquisition Corp. Announces the Closing of its Initial Public Offering and Partial Exercise of Underwriter's Over-Allotment Option to Purchase Additional Units - Wintergreen Acquisition (NASDAQ:WTGUU)

On Tuesday, U.S. indices declined, with the S&P 500 and Nasdaq down 0.71% and 1.03% respectively. Deere (DE) hit a new 52-week high of $677.89, up 43% in a year, with Baird upgrading it to Outperform and raising the target to $800. The Chef's Warehouse (CHEF) also hit a new high, up 79% in a year, but faces valuation concerns. Builders Firstsource (BLDR) and Dave & Buster's (PLAY) hit new lows, down 54% and 65% respectively in a year.

FTSE Russell added 10 Nigerian companies, including Dangote Cement, MTN Nigeria, and Zenith Bank, to its FTSE Frontier Index, reclassifying Nigeria as a Frontier Market. The change takes effect on Sept. 21, aiming to boost global investor interest in Nigerian equities.

Upper Macungie Township approved Eli Lilly's final land development plan for a $3.5 billion pharmaceutical plant. The 797,432-square-foot facility will create 2,000 construction jobs and involve final assembly of injectable medicines. The project will be completed in phases, with the first phase including an amenities building and visitor center.

Northrop Grumman (NOC) secured an $862.85M contract from the U.S. Army for precision guidance kits, extending through 2031. The company offers a 1.82% dividend yield, a 30% payout ratio, and a 10% dividend growth rate over three years. NOC is currently 6.3% undervalued relative to its GF Value™ of $563.93. The company's GF Score™ is 84/100, reflecting strong financial health and operational performance. Insider activity shows $26.4M in insider selling over the past 12 months, while 12 prominent

Novartis reported that remibrutinib, an oral BTK inhibitor, significantly reduced relapse rates compared to teriflunomide in two Phase 3 trials for relapsing multiple sclerosis, with no liver safety signals. Full data, including relapse rates and adverse events, will be presented in October 2026. The drug is not yet approved for MS.

Ford (F) is bidding for the UK Ministry of Defence’s £2 billion Light Mobility Vehicle program, partnering with General Dynamics and Ricardo. The initial contract could be worth £750 million, with broader potential for NATO-wide sales. Ford aims to leverage its Ranger platform and UK manufacturing capabilities. Success could diversify revenue but faces competition and execution risks. The financial impact is uncertain and likely long-term.